Submitted by Anonymous (not verified) on Mon, 02/19/2018 - 18:11
Stem Cell Transplantation Remains Standard of Care in Multiple MyelomaCuretoday.comPatients with multiple myeloma who are eligible for stem cell transplantation should still be considered for high-dose therapy (HDT) even in the novel agent era, according to the authors of a study recently publish